Right from the start, agreements and plans for the development of COVID-19 vaccines, were going to privilege a profit-generating and market-based approach, writes Dale McKinley.
This post was originally published on Green Left.
Right from the start, agreements and plans for the development of COVID-19 vaccines, were going to privilege a profit-generating and market-based approach, writes Dale McKinley.
This post was originally published on Green Left.